ETAR Blockade’s Role in Current and Emerging Therapies for IgAN– Explore the Visual Abstract
This visual abstract was supported by an unrestricted educational grant from Chinook Therapeutics, a Novartis Company.
22Jan
Share
Back to News
Back to News
Related Posts
12Nov
Catch Up at the ISN Academy and Discover What’s in Store for 2025
The ISN Academy is committed to delivering high-quality educational resources to... read more
12Nov
Connecting Global Resources for CKDu: The ISN’s Commitment to Advancing Kidney Health Through Research
The ISN recognizes the importance of global research initiatives in advancing... read more
12Nov
Demystifying Global Kidney Trials: Two New Case Studies in the ‘Guide for Everyone’
The “ISN Global Kidney Trials Insights: A Guide for Everyone”... read more
12Nov
New Partnership to Strengthen Pediatric Nephrology in Latin America and the Caribbean
The ISN is pleased to announce the signing of a new... read more
12Nov
Latest ISN Journal Editorial Selections
Kidney International® Patients With Crush Syndrome and Kidney Disease: Lessons Learned From... read more
12Nov
ISN Educational Ambassadors Program: Strengthening Peritoneal Dialysis in Dakar
Staff from Dalal Jamm Hospital and Cliniques Universitaires St. Luc during... read more
12Nov
Be Part of the ISN’s Global Kidney Community: Expand Your Organization’s Network With the ISN
In 2024, the ISN welcomed new Affiliated and Collective-member societies, extending... read more
12Nov
Enhance Your WCN’25 Experience With the #ISNWCN Social Media Team!
The #ISNWCN Social Media Team will be on hand at WCN’25... read more
12Nov
Call to Action From President Nangaku: Vote in the ISN 2024 Leadership Elections!
The 2024 ISN leadership elections are underway from November 4 to... read more
28Oct
2024 KI-ISN Early-Career Researcher Awards & 2025-2027 ISN-KI Editorial Fellowships: Apply by Dec. 19!
Calling all early-career researchers! Have you published original research in Kidney International®... read more